SCHEMBL25019964

SCHEMBL25019964

CCCCCOc1nc(CC)c(CCCCc2cccc3cc(C)ccc23)c(N2CCNC(CC#N)C2)n1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ PRKCQ Q04759 1/20 0.30
▸ PRKCD Q05655 1/20 0.30
▸ KHK P50053 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19637810 0.78 — —
SCHEMBL25019963 0.75 KRAS (0.45) —
SCHEMBL23715888 0.66 P2RY12 (0.35) —
SCHEMBL23715887 0.65 MEN1 (0.34) —
SCHEMBL22010746 0.65 — —
SCHEMBL25021611 0.64 — —
SCHEMBL25019783 0.64 PRKCQ (0.30) PRKCQPRKCD
Ammonia Solution, Strong SCHEMBL27937820 0.63 CYP1A2 (0.47) —
Ammonia Solution, Strong SCHEMBL27937784 0.63 CYP1A2 (0.47) —
SCHEMBL25019891 0.62 KRAS (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710439-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2023-02-15 — — EP disclosed
Send feedback